BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Périchon B, Goussard S, Walewski V, Krizova L, Cerqueira G, Murphy C, Feldgarden M, Wortman J, Clermont D, Nemec A, Courvalin P. Identification of 50 class D β-lactamases and 65 Acinetobacter-derived cephalosporinases in Acinetobacter spp. Antimicrob Agents Chemother 2014;58:936-49. [PMID: 24277043 DOI: 10.1128/AAC.01261-13] [Cited by in Crossref: 58] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Oliveira H, Mendes A, Fraga AG, Ferreira A, Pimenta AI, Mil-Homens D, Fialho AM, Pedrosa J, Azeredo J. K2 Capsule Depolymerase Is Highly Stable, Is Refractory to Resistance, and Protects Larvae and Mice from Acinetobacter baumannii Sepsis. Appl Environ Microbiol 2019;85:e00934-19. [PMID: 31227554 DOI: 10.1128/AEM.00934-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Vrancianu CO, Gheorghe I, Dobre EG, Barbu IC, Cristian RE, Popa M, Lee SH, Limban C, Vlad IM, Chifiriuc MC. Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens. Int J Mol Sci 2020;21:E8527. [PMID: 33198306 DOI: 10.3390/ijms21228527] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Yoon EJ, Goussard S, Touchon M, Krizova L, Cerqueira G, Murphy C, Lambert T, Grillot-Courvalin C, Nemec A, Courvalin P. Origin in Acinetobacter guillouiae and dissemination of the aminoglycoside-modifying enzyme Aph(3')-VI. mBio 2014;5:e01972-14. [PMID: 25336457 DOI: 10.1128/mBio.01972-14] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
4 Cosgaya C, Ratia C, Marí-Almirall M, Rubio L, Higgins PG, Seifert H, Roca I, Vila J. In vitro and in vivo Virulence Potential of the Emergent Species of the Acinetobacter baumannii (Ab) Group. Front Microbiol 2019;10:2429. [PMID: 31708900 DOI: 10.3389/fmicb.2019.02429] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
5 D'Souza R, Pinto NA, Higgins PG, Hwang I, Yong D, Choi J, Lee K, Chong Y. First Report of the Carbapenemase Gene blaOXA-499 in Acinetobacter pittii. Antimicrob Agents Chemother 2017;61:e02676-16. [PMID: 28264850 DOI: 10.1128/AAC.02676-16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
6 Khosravi AD, Sadeghi P, Shahraki AH, Heidarieh P, Sheikhi N. Molecular Methods for Identification of Acinetobacter Species by Partial Sequencing of the rpoB and 16S rRNA Genes. J Clin Diagn Res 2015;9:DC09-13. [PMID: 26393127 DOI: 10.7860/JCDR/2015/13867.6188] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
7 Powers RA, Swanson HC, Taracila MA, Florek NW, Romagnoli C, Caselli E, Prati F, Bonomo RA, Wallar BJ. Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii. Biochemistry 2014;53:7670-9. [PMID: 25380506 DOI: 10.1021/bi500887n] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
8 Chen FJ, Huang WC, Liao YC, Wang HY, Lai JF, Kuo SC, Lauderdale TL, Sytwu HK. Molecular Epidemiology of Emerging Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter pittii in Taiwan, 2010 to 2014. Antimicrob Agents Chemother 2019;63:e02007-18. [PMID: 30670429 DOI: 10.1128/AAC.02007-18] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
9 Kenyon JJ, Arbatsky NP, Shneider MM, Popova AV, Dmitrenok AS, Kasimova AA, Shashkov AS, Hall RM, Knirel YA. The K46 and K5 capsular polysaccharides produced by Acinetobacter baumannii NIPH 329 and SDF have related structures and the side-chain non-ulosonic acids are 4-O-acetylated by phage-encoded O-acetyltransferases. PLoS One 2019;14:e0218461. [PMID: 31220143 DOI: 10.1371/journal.pone.0218461] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Bush K. Past and Present Perspectives on β-Lactamases. Antimicrob Agents Chemother 2018;62:e01076-18. [PMID: 30061284 DOI: 10.1128/AAC.01076-18] [Cited by in Crossref: 240] [Cited by in F6Publishing: 126] [Article Influence: 60.0] [Reference Citation Analysis]
11 Hammoudi Halat D, Ayoub Moubareck C. The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria. Antibiotics (Basel) 2020;9:E186. [PMID: 32316342 DOI: 10.3390/antibiotics9040186] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 16.0] [Reference Citation Analysis]
12 Touchon M, Cury J, Yoon EJ, Krizova L, Cerqueira GC, Murphy C, Feldgarden M, Wortman J, Clermont D, Lambert T, Grillot-Courvalin C, Nemec A, Courvalin P, Rocha EP. The genomic diversification of the whole Acinetobacter genus: origins, mechanisms, and consequences. Genome Biol Evol 2014;6:2866-82. [PMID: 25313016 DOI: 10.1093/gbe/evu225] [Cited by in Crossref: 158] [Cited by in F6Publishing: 138] [Article Influence: 19.8] [Reference Citation Analysis]
13 Monem S, Furmanek-Blaszk B, Łupkowska A, Kuczyńska-Wiśnik D, Stojowska-Swędrzyńska K, Laskowska E. Mechanisms Protecting Acinetobacter baumannii against Multiple Stresses Triggered by the Host Immune Response, Antibiotics and Outside-Host Environment. Int J Mol Sci 2020;21:E5498. [PMID: 32752093 DOI: 10.3390/ijms21155498] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
14 Cecchini T, Yoon EJ, Charretier Y, Bardet C, Beaulieu C, Lacoux X, Docquier JD, Lemoine J, Courvalin P, Grillot-Courvalin C, Charrier JP. Deciphering Multifactorial Resistance Phenotypes in Acinetobacter baumannii by Genomics and Targeted Label-free Proteomics. Mol Cell Proteomics 2018;17:442-56. [PMID: 29259044 DOI: 10.1074/mcp.RA117.000107] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
15 Shen Z, Sheh A, Young SK, Abouelliel A, Ward DV, Earl AM, Fox JG. Draft genome sequences of six enterohepatic helicobacter species isolated from humans and one from rhesus macaques. Genome Announc 2014;2:e00857-14. [PMID: 25212613 DOI: 10.1128/genomeA.00857-14] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
16 Athanasakopoulou Z, Reinicke M, Diezel C, Sofia M, Chatzopoulos DC, Braun SD, Reissig A, Spyrou V, Monecke S, Ehricht R, Tsilipounidaki K, Giannakopoulos A, Petinaki E, Billinis C. Antimicrobial Resistance Genes in ESBL-Producing Escherichia coli Isolates from Animals in Greece. Antibiotics (Basel) 2021;10:389. [PMID: 33916633 DOI: 10.3390/antibiotics10040389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhu Y, Lu J, Zhao J, Zhang X, Yu HH, Velkov T, Li J. Complete genome sequence and genome-scale metabolic modelling of Acinetobacter baumannii type strain ATCC 19606. Int J Med Microbiol 2020;310:151412. [PMID: 32081464 DOI: 10.1016/j.ijmm.2020.151412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Pulami D, Schauss T, Eisenberg T, Blom J, Schwengers O, Bender JK, Wilharm G, Kämpfer P, Glaeser SP. Acinetobacter stercoris sp. nov. isolated from output source of a mesophilic german biogas plant with anaerobic operating conditions. Antonie Van Leeuwenhoek 2021;114:235-51. [PMID: 33591460 DOI: 10.1007/s10482-021-01517-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
19 Karah N, Jolley KA, Hall RM, Uhlin BE. Database for the ampC alleles in Acinetobacter baumannii. PLoS One 2017;12:e0176695. [PMID: 28459877 DOI: 10.1371/journal.pone.0176695] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
20 Montaña S, Schramm ST, Traglia GM, Chiem K, Parmeciano Di Noto G, Almuzara M, Barberis C, Vay C, Quiroga C, Tolmasky ME, Iriarte A, Ramírez MS. The Genetic Analysis of an Acinetobacter johnsonii Clinical Strain Evidenced the Presence of Horizontal Genetic Transfer. PLoS One 2016;11:e0161528. [PMID: 27548264 DOI: 10.1371/journal.pone.0161528] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
21 Roy S, Chowdhury G, Mukhopadhyay AK, Dutta S, Basu S. Convergence of Biofilm Formation and Antibiotic Resistance in Acinetobacter baumannii Infection. Front Med 2022;9:793615. [DOI: 10.3389/fmed.2022.793615] [Reference Citation Analysis]
22 Gan HM, Wengert P, Barton HA, Hudson AO, Savka MA. Insight into the resistome and quorum sensing system of a divergent Acinetobacter pittii isolate from an untouched site of the Lechuguilla Cave. Access Microbiol 2020;2:acmi000089. [PMID: 34568753 DOI: 10.1099/acmi.0.000089] [Reference Citation Analysis]
23 Bouza AA, Swanson HC, Smolen KA, VanDine AL, Taracila MA, Romagnoli C, Caselli E, Prati F, Bonomo RA, Powers RA, Wallar BJ. Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase. ACS Infect Dis 2018;4:325-36. [PMID: 29144724 DOI: 10.1021/acsinfecdis.7b00152] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
24 Philippon A, Arlet G, Labia R, Iorga BI. Class C β-Lactamases: Molecular Characteristics. Clin Microbiol Rev 2022;:e0015021. [PMID: 35435729 DOI: 10.1128/cmr.00150-21] [Reference Citation Analysis]
25 Skalweit MJ, Li M, Taracila MA. Effect of asparagine substitutions in the YXN loop of a class C β-lactamase of Acinetobacter baumannii on substrate and inhibitor kinetics. Antimicrob Agents Chemother 2015;59:1472-7. [PMID: 25534745 DOI: 10.1128/AAC.03537-14] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Vrancianu CO, Gheorghe I, Czobor IB, Chifiriuc MC. Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii. Microorganisms 2020;8:E935. [PMID: 32575913 DOI: 10.3390/microorganisms8060935] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
27 Bush K, Bradford PA. Epidemiology of β-Lactamase-Producing Pathogens. Clin Microbiol Rev 2020;33:e00047-19. [PMID: 32102899 DOI: 10.1128/CMR.00047-19] [Cited by in Crossref: 112] [Cited by in F6Publishing: 59] [Article Influence: 56.0] [Reference Citation Analysis]
28 Maravić A, Skočibušić M, Fredotović Ž, Šamanić I, Cvjetan S, Knezović M, Puizina J. Urban riverine environment is a source of multidrug-resistant and ESBL-producing clinically important Acinetobacter spp. Environ Sci Pollut Res Int 2016;23:3525-35. [PMID: 26490931 DOI: 10.1007/s11356-015-5586-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]